Correlation Engine 2.0
Clear Search sequence regions

  • adult (2)
  • candida (1)
  • child (1)
  • humans (1)
  • interferon α (1)
  • molluscum contagiosum (8)
  • mumps (1)
  • ok 432 (1)
  • patients (1)
  • rubella (1)
  • tuberculin (3)
  • vitamin d3 (1)
  • Sizes of these terms reflect their relevance to your search.

    Molluscum contagiosum (MC) is a common cutaneous viral infection with no standard treatment. The virus responsible for MC is thought to be cleared by cell mediated immunity (CMI). Intralesional immunotherapy that stimulates CMI has been shown to be an effective treatment for other cutaneous viruses. In this review, we evaluate the efficacy and safety of intralesional immunotherapy in the treatment of MC. Articles met inclusion criteria if they examined the effects of intralesional immunotherapy as a treatment for MC, with a clear outcome and reproducible methodology. 228 studies were screened and 10 studies met criteria for inclusion. Intralesional immunotherapies investigated included candida, combined measles, mumps, rubella vaccine, tuberculin purified protein derivative, vitamin D3, interferon α, and Streptococcal substrain OK-432. Studies demonstrated clearance of MC lesions following intralesional immunotherapy, with complete response rates between 36% and 100%. No serious adverse effects were noted. Intralesional immunotherapy is a safe and effective treatment option for MC in pediatric and adult patients. © 2020 Wiley Periodicals LLC.


    Amy Wells, Sami K Saikaly, Jennifer J Schoch. Intralesional immunotherapy for molluscum contagiosum: A review. Dermatologic therapy. 2020 Nov;33(6):e14386

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33044025

    View Full Text